News | May 09, 2024
Piramal Pharma launches new campaign for 'Polycrol' with Brand Ambassador Jisshu Sengupta
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
The product is used to treat amyotrophic lateral sclerosis
Investing in Malaysia's largest clinic operator to expand the healthcare business
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
The Unit currently caters to emerging markets of Latin America and Africa with a variety of dosage forms
Travoprost Ophthalmic Solution USP, 0.004%, is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
The project funding will be done through a mix of internal accruals and debts.
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastatic cervical cancer
Subscribe To Our Newsletter & Stay Updated
